A human coronavirus evolves antigenically to escape antibody immunity

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209

IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era

Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586

ETE 3: Reconstruction, Analysis, and Visualization of Phylogenomic Data

Huerta‐Cepas, J., Serra, F., & Bork, P. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw046 · Cited by 2,255

SARS-CoV-2 vaccines in development

Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956

Identification of a new human coronavirus

van der Hoek, L., Pyrć, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Dillen, P. M. E. W., Kaandorp, J. C., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,868

Mapping the Antigenic and Genetic Evolution of Influenza Virus

Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2004) · Science · doi:10.1126/science.1097211 · Cited by 1,868

dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering

Galili, T. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv428 · Cited by 1,826

Evolution of antibody immunity to SARS-CoV-2

Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Piccoli, L., Park, Y.-J., Tortorici, M. A., Czudnochowski, N., Walls, A. C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L. E., Bowen, J. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.037 · Cited by 1,395

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc6952 · Cited by 1,385

Unifying the Epidemiological and Evolutionary Dynamics of Pathogens

Grenfell, B. T., Pybus, O. G., Gog, J. R., Wood, J. L. N., Daly, J. M., MUMFORD, J. A., & Holmes, E. C. (2004) · Science · doi:10.1126/science.1090727 · Cited by 1,370

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2571-7 · Cited by 1,349

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343

Viral Mutation Rates

Sanjuán, R., Nebot, M. R., Chirico, N., Mansky, L. M., & Belshaw, R. D. (2010) · Journal of Virology · doi:10.1128/jvi.00694-10 · Cited by 1,313

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Rogers, T. F., Zhao, F., Huang, D., Beutler, N., Burns, A., He, W.-T., Limbo, O., Smith, C., Song, G., Woehl, J., et al. (2020) · Science · doi:10.1126/science.abc7520 · Cited by 1,230

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195

TreeTime: Maximum-likelihood phylodynamic analysis

Sagulenko, P., Puller, V., & Neher, R. A. (2017) · Virus Evolution · doi:10.1093/ve/vex042 · Cited by 1,185

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

Tan, C. W., Chia, W. N., Qin, X., Liu, P., Chen, M. I.-C., Tiu, C. K., Hu, Z., Chen, V. C.-W., Young, B. E., Sia, W. R., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0631-z · Cited by 1,182

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Oosthuysen, B., Lambson, B. E., de Oliveira, T., Vermeulen, M., van der Berg, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01285-x · Cited by 1,147

SARS-CoV-2 evolution during treatment of chronic infection

Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097

Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques

McMahan, K., Yu, J., Mercado, N. B., Loos, C., Tostanoski, L. H., Chandrashekar, A., Liu, J., Peter, L., Atyeo, C., Zhu, A., et al. (2021) · Nature · doi:10.1038/s41586-020-03041-6 · Cited by 1,068

Potently neutralizing and protective human antibodies against SARS-CoV-2

Zost, S. J., Gilchuk, P., Case, J. B., Binshtein, E., Chen, R. E., Nkolola, J. P., Schäfer, A., Reidy, J. X., Trivette, A., Nargi, R. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2548-6 · Cited by 1,041

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2025179 · Cited by 1,021

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H. D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.007 · Cited by 1,016

Human aminopeptidase N is a receptor for human coronavirus 229E

Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., & Holmes, K. V. (1992) · Nature · doi:10.1038/357420a0 · Cited by 941

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940

A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome.

(1994) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040152 · Cited by 920

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, M., De Marco, A., Lempp, F. A., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.028 · Cited by 901

A New Virus Isolated from the Human Respiratory Tract.

Hamre, D. M., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 888

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2021) · New England Journal of Medicine · doi:10.1056/nejmc2036242 · Cited by 831

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824

GARD: a genetic algorithm for recombination detection

Pond, S. L. K., Posada, D., Gravenor, M. B., Woelk, C. H., & Frost, S. D. W. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl474 · Cited by 811

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Barnes, C. O., West, A. P., Huey-Tubman, K. E., Hoffmann, M. A. G., Sharaf, N. G., Hoffman, P. R., Koranda, N., Gristick, H. B., Gaebler, C., Muecksch, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.025 · Cited by 795

Structural insights into coronavirus entry

(2019) · Advances in Virus Research · doi:10.1016/bs.aivir.2019.08.002 · Cited by 769

Seasonal coronavirus protective immunity is short-lasting

Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Crawford, K. H. D., Eguia, R. T., Dingens, A. S., Loes, A. N., Malone, K. D., Wolf, C. R., Chu, H. Y., Tortorici, M. A., Veesler, D., Murphy, M., et al. (2020) · Viruses · doi:10.3390/v12050513 · Cited by 744

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Starr, T. N., Greaney, A. J., Addetia, A., Hannon, W. W., Choudhary, M. C., Dingens, A. S., Li, J. Z., & Bloom, J. D. (2021) · Science · doi:10.1126/science.abf9302 · Cited by 743

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Widge, A. T., Rouphael, N. G., Jackson, L. A., Anderson, E. J., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2032195 · Cited by 722

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Network for Genomic Surveillance in South Africa, Cele, S., COMMIT-KZN Team, Gazy, I., Jackson, L., Hwa, S.-H., Tegally, H., Lustig, G., Giandhari, J., Pillay, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03471-w · Cited by 651

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Rodda, L. B., Netland, J., Shehata, L., Pruner, K. B., Morawski, P. A., Thouvenel, C. D., Takehara, K. K., Eggenberger, J., Hemann, E. A., Waterman, H. R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.029 · Cited by 647

The time course of the immune response to experimental coronavirus infection of man

Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021) · Science · doi:10.1126/science.abf6950 · Cited by 535

Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate

Addetia, A., Crawford, K. H. D., Dingens, A., Zhu, H., Roychoudhury, P., Huang, M.-L., Jerome, K. R., Bloom, J. D., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02107-20 · Cited by 525

Coronaviruses

Denison, M. R., Graham, R. L., Donaldson, E., Eckerle, L. D., & Baric, R. S. (2011) · RNA Biology · doi:10.4161/rna.8.2.15013 · Cited by 501

Antibody landscapes after influenza virus infection or vaccination

Fonville, J. M., Wilks, S. H., James, S. L., Fox, A., Ventresca, M., Aban, M., Xue, L., Jones, T. C., H., L. N. M., Thái, P. Q., et al. (2014) · Science · doi:10.1126/science.1256427 · Cited by 475

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., et al. (2008) · Nature · doi:10.1038/nature07231 · Cited by 457

IMMUNITY TO INFLUENZA IN MAN

Couch, R. B., & Kasel, J. A. (1983) · Annual Review of Microbiology · doi:10.1146/annurev.mi.37.100183.002525 · Cited by 426

Unifying Viral Genetics and Human Transportation Data to Predict the Global Transmission Dynamics of Human Influenza H3N2

Lemey, P., Rambaut, A., Bedford, T., Faria, N. R., Bielejec, F., Baele, G., Russell, C. A., Smith, D. J., Pybus, O. G., Brockmann, D., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003932 · Cited by 413

Integrating influenza antigenic dynamics with molecular evolution

Bedford, T., Suchard, M. A., Lemey, P., Dudas, G., Gregory, V., Hay, A. J., McCauley, J. W., Russell, C. A., Smith, D. J., & Rambaut, A. (2014) · eLife · doi:10.7554/elife.01914 · Cited by 401

Long term trends in the evolution of H(3) HA1 human influenza type A.

Fitch, W. M., Bush, R. M., Bender, C. A., & Cox, N. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7712 · Cited by 394

Human coronaviruses OC43 and HKU1 bind to 9- O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A

Hulswit, R. J. G., Lang, Y., Bakkers, M. J. G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F. J. M., Boons, G., Bosch, B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809667116 · Cited by 384

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Suryadevara, N., Shrihari, S., Gilchuk, P., VanBlargan, L. A., Binshtein, E., Zost, S. J., Nargi, R. S., Sutton, R. E., Winkler, E. S., Chen, E. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.029 · Cited by 345

TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium

Bertram, S., Dijkman, R., Habjan, M., Heurich, A., Gierer, S., Glowacka, I., Welsch, K., Winkler, M., Schneider, H., Hofmann-Winkler, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03372-12 · Cited by 341

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Crawford, K. H. D., Dingens, A. S., Eguia, R., Wolf, C. R., Wilcox, N., Logue, J. K., Shuey, K., Casto, A. M., Fiala, B., Wrenn, S., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa618 · Cited by 265

Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses

Sandbulte, M. R., Westgeest, K. B., Gao, J., Xu, X., Klimov, A. I., Russell, C. A., Burke, D. F., Smith, D. J., Fouchier, R. A. M., & Eichelberger, M. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113801108 · Cited by 264

Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses

Neher, R. A., Bedford, T., Daniels, R. S., Russell, C. A., & Shraiman, B. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525578113 · Cited by 233

The human coronavirus HCoV-229E S-protein structure and receptor binding

Li, Z., Tomlinson, A. C. A., Wong, A. H. M., Zhou, D., Desforges, M., Talbot, P. J., Benlekbir, S., Rubinstein, J. L., & Rini, J. M. (2019) · eLife · doi:10.7554/elife.51230 · Cited by 222

Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants

Lee, J. M., Huddleston, J., Doud, M. B., Hooper, K. A., Wu, N. C., Bedford, T., & Bloom, J. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806133115 · Cited by 207

The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin

Thyagarajan, B., & Bloom, J. D. (2014) · eLife · doi:10.7554/elife.03300 · Cited by 202

A simple protein-based surrogate neutralization assay for SARS-CoV-2

Abe, K. T., Li, Z., Samson, R., Samavarchi‐Tehrani, P., Valcourt, E. J., Wood, H., Budylowski, P., Dupuis, A. P., Girardin, R. C., Rathod, B., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142362 · Cited by 200

Immune history shapes specificity of pandemic H1N1 influenza antibody responses

Li, Y., Myers, J. L., Bostick, D., Sullivan, C. B., Madara, J. J., Linderman, S. L., Liu, Q., Carter, D. M., Wrammert, J., Esposito, S., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130212 · Cited by 185

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

Alsoussi, W. B., Turner, J. S., Case, J. B., Zhao, H., Schmitz, A. J., Zhou, J. Q., Chen, R. E., Lei, T., Rizk, A. A., McIntire, K. M., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000583 · Cited by 181

Phylogenetic Analysis Reveals the Global Migration of Seasonal Influenza A Viruses

Nelson, M. I., Simonsen, L., Viboud, C. G., Miller, M. A., & Holmes, E. C. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030131 · Cited by 158

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein

Zhou, H., Chen, Y., Zhang, S., Niu, P., Qin, K., Jia, W., Huang, B., Zhang, S., Lan, J., Zhang, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10897-4 · Cited by 148

The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains

Reed, S. E. (1984) · Journal of Medical Virology · doi:10.1002/jmv.1890130208 · Cited by 147

Age-specific differences in the dynamics of protective immunity to influenza

Ranjeva, S., Subramanian, R., Fang, V. J., Leung, G., Ip, D., Perera, R. A. P. M., Peiris, J. M. M., Cowling, B., & Cobey, S. (2018) · Nature Communications · doi:10.1038/s41467-019-09652-6 · Cited by 141

Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Liu, Z., VanBlargan, L. A., Bloyet, L.-M., Rothlauf, P. W., Chen, R. E., Stumpf, S., Zhao, H., Errico, J. M., Theel, E. S., Liebeskind, M. J., et al. (2020) · doi:10.1101/2020.11.06.372037 · Cited by 135

Biophysical Models of Protein Evolution: Understanding the Patterns of Evolutionary Sequence Divergence

Echave, J., & Wilke, C. O. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-033819 · Cited by 133

Protease-Mediated Entry via the Endosome of Human Coronavirus 229E

Kawase, M., Shirato, K., Matsuyama, S., & Taguchi, F. (2008) · Journal of Virology · doi:10.1128/jvi.01933-08 · Cited by 128

Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection

Callow, K. A. (1985) · Journal of Hygiene · doi:10.1017/s0022172400062410 · Cited by 119

Coronavirus infections in working adults. Eight-year study with 229 E and OC 43.

Hendley, J. O., Fishburne, H. B., & Gwaltney, J. M. (1972) · PubMed · doi:10.1164/arrd.1972.105.5.805 · Cited by 118

Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin

Lee, J. M., Eguia, R. T., Zost, S. J., Choudhary, S., Wilson, P. C., Bedford, T., Stevens‐Ayers, T., Boeckh, M., Hurt, A. C., Lakdawala, S. S., et al. (2019) · eLife · doi:10.7554/elife.49324 · Cited by 112

Receptor-binding loops in alphacoronavirus adaptation and evolution

Wong, A. H. M., Tomlinson, A. C. A., Zhou, D., Satkunarajah, M., Chen, K., Sharon, C., Desforges, M., Talbot, P. J., & Rini, J. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01706-x · Cited by 110

Strength and tempo of selection revealed in viral gene genealogies

Bedford, T., Cobey, S. E., & Pascual, M. (2011) · BMC Evolutionary Biology · doi:10.1186/1471-2148-11-220 · Cited by 95

Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e

Kistler, K. E., & Bedford, T. (2021) · eLife · doi:10.7554/elife.64509 · Cited by 94

Evolution of Viral Genomes: Interplay Between Selection, Recombination, and Other Forces

Spielman, S. J., Weaver, S., Shank, S. D., Magalis, B. R., Li, M., & Pond, S. L. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9074-0_14 · Cited by 80

Genetic drift of human coronavirus OC43 spike gene during adaptive evolution

Ren, L., Zhang, Y., Li, J., Xiao, Y., Zhang, J., Wang, Y., Chen, L., Paranhos‐Baccalà, G., & Wang, J. (2015) · Scientific Reports · doi:10.1038/srep11451 · Cited by 76

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study

Aldridge, R. W., Lewer, D., Beale, S., Johnson, A. M., Zambon, M. C. F. A., Hayward, A. C., Fragaszy, E., & Flu Watch Group (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15812.2 · Cited by 71

Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains

Chibo, D., & Birch, C. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81662-0 · Cited by 70

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Dingens, A. S., Crawford, K. H. D., Adler, A., Steele, S. L., Lacombe, K., Eguia, R. T., Amanat, F., Walls, A. C., Wolf, C. R., Murphy, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18178-1 · Cited by 69

Evolution of Viral Genomes: Interplay Between Selection, Recombination, and Other Forces

Pond, S. L. K., Murrell, B., & Poon, A. F. Y. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-585-5_10 · Cited by 68

Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins

Fulton, B. O., Sachs, D. M., Beaty, S. M., Won, S. T., Lee, B., Palese, P., & Heaton, N. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.054 · Cited by 68

Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins

Muñoz-Alía, M. Á., Nace, R. A., Zhang, L., & Russell, S. J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100225 · Cited by 60

RISES IN TITERS OF ANTIBODY TO HUMAN CORONA VIRUSES OC43 AND 229E IN SEATTLE FAMILIES DURING 1975–1979

Schmidt, O. W., ALLAN, I. D., Cooney, M. K., Foy, H. M., & Fox, J. P. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114315 · Cited by 49

Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection

Fonville, J. M., Fraaij, P. L. A., de Mutsert, G., Wilks, S., van Beek, R., Fouchier, R. A. M., & Rimmelzwaan, G. F. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv367 · Cited by 42

Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004–2008 depend on the S1 region sequence of the spike protein

Shirato, K., Kawase, M., Watanabe, O., Hirokawa, C., Matsuyama, S., Nishimura, H., & Taguchi, F. (2012) · Journal of General Virology · doi:10.1099/vir.0.043117-0 · Cited by 40

Phylogenomics and bioinformatics of SARS-CoV

Lió, P. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.01.005 · Cited by 36

A simple protein-based surrogate neutralization assay for SARS-CoV-2Preprint

Abe, K. T., Li, Z., Samson, R., Samavarchi-Tehrani, P., Valcourt, E. J., Wood, H., Budylowski, P., Dupuis, A. P., Girardin, R. C., Rathod, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.10.197913 · Cited by 20

Functional SARS-CoV-2-specific immune memory persists after mild COVID-19

Rodda, L. B., Netland, J., Shehata, L., Pruner, K. B., Morwaski, P. A., Thouvenel, C. D., Takehara, K. K., Eggenberger, J., Hemann, E. A., Waterman, H. R., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.206.supp.62.06 · Cited by 18

Serology and Energetics of Cross-Reactions Among the H3 Antigens of Influenza Viruses

Underwood, P. A. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.397-404.1980 · Cited by 16

Coronavirus Infections in Working Adults

Hendley, J. O., Fishburne, H. B., & Gwaltney, J. M. (2015) · American Review of Respiratory Disease · Cited by 15

Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229EPreprint

Kistler, K. E., & Bedford, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.30.352914 · Cited by 14

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Suryadevara, N., Shrihari, S., Gilchuk, P., VanBlargan, L. A., Binshtein, E., Zost, S. J., Nargi, R. S., Sutton, R. E., Winkler, E. S., Chen, E. C., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.206.supp.30.13 · Cited by 7

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Carabelli, A. M., Peacock, T. P., Thorne, L., Harvey, W. T., Hughes, J., de Silva, T. I., Peacock, S. J., Barclay, W., de Silva, T. I., Towers, G. J., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00841-7 · Cited by 1,386

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178

The biological and clinical significance of emerging SARS-CoV-2 variants

Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Starr, T. N., Czudnochowski, N., Liu, Z., Zatta, F., Park, Y., Addetia, A., Pinto, D., Beltramello, M., Hernandez, P., Greaney, A. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03807-6 · Cited by 503

An atlas of continuous adaptive evolution in endemic human viruses

Kistler, K. E., & Bedford, T. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.09.012 · Cited by 65

The evolutionary dynamics of endemic human coronaviruses

Jo, W. K., Drosten, C., & Drexler, J. F. (2021) · Virus Evolution · doi:10.1093/ve/veab020 · Cited by 60

An Atlas of Adaptive Evolution in Endemic Human VirusesPreprint

Kistler, K., & Bedford, T. (2023) · bioRxiv · doi:10.1101/2023.05.19.541367 · Cited by 1

Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229EPreprint

Kistler, K. E., & Bedford, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.30.352914 · Cited by 14

Mutations to the HCoV-229E spike have counterbalancing effects on serum antibody neutralization and receptor bindingPreprint

Harari, S., Eguia, R. T., Dadonaite, B., Radford, C. E., Stewart, C., Veesler, D., & Bloom, J. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.22.707297 · Cited by 1